Reena Halai

2.7k total citations
17 papers, 1.2k citations indexed

About

Reena Halai is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Reena Halai has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Reena Halai's work include Receptor Mechanisms and Signaling (8 papers), Complement system in diseases (5 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Reena Halai is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Complement system in diseases (5 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Reena Halai collaborates with scholars based in Australia, United Kingdom and United States. Reena Halai's co-authors include Matthew A. Cooper, David J. Craik, Mark A. T. Blaskovich, Mark S. Butler, Karl A. Hansford, Trent M. Woodruff, Zoe Schofield, Sarah E. Corcoran, Mike C. L. Wu and Quentin Kaas and has published in prestigious journals such as Journal of Biological Chemistry, Bioinformatics and Brain.

In The Last Decade

Reena Halai

16 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reena Halai Australia 13 789 282 137 104 91 17 1.2k
David Monteith United States 21 814 1.0× 133 0.5× 59 0.4× 40 0.4× 60 0.7× 51 1.4k
Akihiro Muto Japan 20 803 1.0× 411 1.5× 35 0.3× 52 0.5× 57 0.6× 36 1.5k
InSug O‐Sullivan United States 21 873 1.1× 366 1.3× 97 0.7× 336 3.2× 47 0.5× 50 1.7k
Débora Levy Brazil 21 583 0.7× 218 0.8× 77 0.6× 32 0.3× 30 0.3× 85 1.4k
Jinlong Yu China 20 612 0.8× 83 0.3× 59 0.4× 24 0.2× 71 0.8× 64 1.1k
Vasily M. Gelfanov United States 19 866 1.1× 165 0.6× 199 1.5× 34 0.3× 238 2.6× 49 1.7k
Deborah A. Rathjen Australia 17 352 0.4× 313 1.1× 74 0.5× 28 0.3× 21 0.2× 40 900
Tsuneo Suzuki Japan 17 549 0.7× 583 2.1× 90 0.7× 37 0.4× 66 0.7× 67 1.3k
Jesse D. Vargas United States 13 849 1.1× 387 1.4× 48 0.4× 14 0.1× 39 0.4× 17 1.5k
Sylwia Bartoszewska Poland 27 1.0k 1.3× 129 0.5× 27 0.2× 196 1.9× 28 0.3× 43 1.9k

Countries citing papers authored by Reena Halai

Since Specialization
Citations

This map shows the geographic impact of Reena Halai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reena Halai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reena Halai more than expected).

Fields of papers citing papers by Reena Halai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reena Halai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reena Halai. The network helps show where Reena Halai may publish in the future.

Co-authorship network of co-authors of Reena Halai

This figure shows the co-authorship network connecting the top 25 collaborators of Reena Halai. A scholar is included among the top collaborators of Reena Halai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reena Halai. Reena Halai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Albornoz, Eduardo A., Karine Mardon, Rajiv Bhalla, et al.. (2025). PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models. Brain.
2.
Corcoran, Sarah E., Reena Halai, & Matthew A. Cooper. (2021). Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950. Pharmacological Reviews. 73(3). 968–1000. 122 indexed citations
3.
Schofield, Zoe, Daniel E. Croker, Avril A. B. Robertson, et al.. (2018). Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling. Scientific Reports. 8(1). 17819–17819. 6 indexed citations
4.
Croker, Daniel E., Peter N. Monk, Reena Halai, et al.. (2016). Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling. Immunology and Cell Biology. 94(8). 787–795. 60 indexed citations
5.
Butler, Mark S., Karl A. Hansford, Mark A. T. Blaskovich, Reena Halai, & Matthew A. Cooper. (2014). Glycopeptide antibiotics: Back to the future. The Journal of Antibiotics. 67(9). 631–644. 227 indexed citations
6.
Halai, Reena, William J. Branchett, James B. Smadbeck, et al.. (2014). Derivation of ligands for the complement C3a receptor from the C-terminus of C5a. European Journal of Pharmacology. 745. 176–181. 14 indexed citations
7.
Croker, Daniel E., Reena Halai, Geraldine Kaeslin, et al.. (2014). C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β‐arrestin recruitment. Immunology and Cell Biology. 92(7). 631–639. 55 indexed citations
8.
Schofield, Zoe, Trent M. Woodruff, Reena Halai, Mike C. L. Wu, & Matthew A. Cooper. (2013). Neutrophils—A Key Component of Ischemia-Reperfusion Injury. Shock. 40(6). 463–470. 181 indexed citations
9.
Croker, Daniel E., Reena Halai, David P. Fairlie, & Matthew A. Cooper. (2013). C5a, but not C5a‐des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2. Immunology and Cell Biology. 91(10). 625–633. 41 indexed citations
10.
Halai, Reena & Matthew A. Cooper. (2012). Using label-free screening technology to improve efficiency in drug discovery. Expert Opinion on Drug Discovery. 7(2). 123–131. 31 indexed citations
11.
Halai, Reena, Daniel E. Croker, Jacky Y. Suen, David P. Fairlie, & Matthew A. Cooper. (2012). A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling. Biosensors. 2(3). 273–290. 11 indexed citations
12.
Croker, Daniel E., Reena Halai, David P. Fairlie, & Matthew A. Cooper. (2012). Ligand-induced dimerisation of the complement C5aR and C5L2 receptors by C5a but not C5a-des Arg. Immunobiology. 217(11). 1181–1182. 2 indexed citations
13.
Halai, Reena, Brid Callaghan, Norelle L. Daly, et al.. (2011). Effects of Cyclization on Stability, Structure, and Activity of α-Conotoxin RgIA at the α9α10 Nicotinic Acetylcholine Receptor and GABAB Receptor. Journal of Medicinal Chemistry. 54(19). 6984–6992. 57 indexed citations
14.
Halai, Reena & David J. Craik. (2009). Conotoxins: natural product drug leads. Natural Product Reports. 26(4). 526–526. 113 indexed citations
15.
Halai, Reena, Richard J. Clark, Simon T. Nevin, et al.. (2009). Scanning Mutagenesis of α-Conotoxin Vc1.1 Reveals Residues Crucial for Activity at the α9α10 Nicotinic Acetylcholine Receptor. Journal of Biological Chemistry. 284(30). 20275–20284. 78 indexed citations
16.
Clark, Richard J., Norelle L. Daly, Reena Halai, et al.. (2008). The three‐dimensional structure of the analgesic α‐conotoxin, RgIA. FEBS Letters. 582(5). 597–602. 28 indexed citations
17.
Kaas, Quentin, et al.. (2007). ConoServer, a database for conopeptide sequences and structures. Bioinformatics. 24(3). 445–446. 183 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026